Cellceutix Ushers in 2012 With Plans for Clinical Trials for Anti-Cancer and ... - Marketwire (press release)

Cellceutix Ushers in 2012 With Plans for Clinical Trials for Anti-Cancer and ... Marketwire (press release) Regarding Cellceutix's drug for the treatment of psoriasis , KM-133, the Company has optimized the drug and has realized writing the patent application. Cellceutix's intellectual property legal instrument firm, Ladas & Parry, will now be entry of patents for ... and more » Link To Article